In the MDA-MB-231 model, treatment with 500 ng/μL LA-CB1 resulted in a reduction of tumor weight by more than 70%, a decrease comparable to the effects of Abemaciclib (Fig. 2G-H). Here, CNR1 is linked to neoplasm.